These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7829873)

  • 1. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth-inhibitory effects of methotrexate.
    Jeffes EW; McCullough JL; Pittelkow MR; McCormick A; Almanzor J; Liu G; Dang M; Voss K; Voss J; Schlotzhauer A
    J Invest Dermatol; 1995 Feb; 104(2):183-8. PubMed ID: 7829873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate treatment provokes apoptosis of proliferating keratinocyte in psoriasis patients.
    Elango T; Thirupathi A; Subramanian S; Ethiraj P; Dayalan H; Gnanaraj P
    Clin Exp Med; 2017 Aug; 17(3):371-381. PubMed ID: 27435483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic and immunologic effects of methotrexate in psoriasis.
    Weinstein GD; Jeffes E; McCullough JL
    J Invest Dermatol; 1990 Nov; 95(5 Suppl):49S-52S. PubMed ID: 16788633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate normalized keratinocyte activation cycle by overturning abnormal keratins as well as deregulated inflammatory mediators in psoriatic patients.
    Elango T; Thirupathi A; Subramanian S; Dayalan H; Gnanaraj P
    Clin Chim Acta; 2015 Dec; 451(Pt B):329-37. PubMed ID: 26499845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
    Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
    Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
    Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
    Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
    Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
    Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclosporin on human epidermal keratinocytes in vitro.
    Dykes PJ; Brunt J; Marks R
    Br J Dermatol; 1990 Feb; 122(2):173-80. PubMed ID: 2317446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of methotrexate and nicotinamide by cerosomes for topical psoriasis treatment with enhanced efficacy.
    Yang X; Tang Y; Wang M; Wang Y; Wang W; Pang M; Xu Y
    Int J Pharm; 2021 Aug; 605():120826. PubMed ID: 34171426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the expression of the stromal cell-derived factor-1 alpha (CXCL 12) in psoriatic patients after treatment with Methotrexate.
    Abdelaal NH; Elhefnawy NG; Abdulmonem SR; Sayed S; Saleh NA; Saleh MA
    J Cosmet Dermatol; 2020 Jan; 19(1):253-258. PubMed ID: 31116013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S; Mahajan R
    Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent effects of methotrexate on the clonal growth of T and B lymphocytes and synovial adherent cells from patients with rheumatoid arthritis.
    Nakajima A; Hakoda M; Yamanaka H; Kamatani N; Kashiwazaki S
    Ann Rheum Dis; 1996 Apr; 55(4):237-42. PubMed ID: 8733440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two patterns of skin ulceration induced by methotrexate in patients with psoriasis.
    Lawrence CM; Dahl MG
    J Am Acad Dermatol; 1984 Dec; 11(6):1059-65. PubMed ID: 6512051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate induces differentiation of human keratinocytes.
    Schwartz PM; Barnett SK; Atillasoy ES; Milstone LM
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):594-8. PubMed ID: 1731329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-Coupled Topical Methotrexate Can Normalize Immune Responses and Induce Tissue Remodeling in Psoriasis.
    Özcan A; Sahin D; Impellizzieri D; Nguyen TT; Hafner J; Yawalkar N; Kurzbach D; Tan G; Akdis CA; Nilsson J; Boyman O; Kolios AGA
    J Invest Dermatol; 2020 May; 140(5):1003-1014.e8. PubMed ID: 31678057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.